Literature DB >> 12806179

Differential expression of estrogen receptors alpha and beta in the spinal cord during postnatal development: localization in glial cells.

Paola Platania1, Floriana Laureanti, Maria Bellomo, Rosario Giuffrida, Anna Maria Giuffrida-Stella, Maria Vincenza Catania, Maria Angela Sortino.   

Abstract

Estrogens are recognized as neuroprotective and neurotrophic agents in the central nervous system. They are involved in neuronal differentiation and survival and promote neural development. Estrogen receptors alpha (ER-alpha) and beta (ER-beta) are predominantly expressed in neurons, whereas their presence in glial cells in vivo is more controversial. Changes in their expression during development have been described in different brain areas, but little is known about their presence in the spinal cord. We have carried out an immunohistochemical study in an attempt to analyze the expression of both ERs in astrocytes and oligodendrocytes of the rat spinal cord and their modifications during postnatal development. RT-PCR analysis of whole spinal cord extracts from 4-, 12-, and 25-day-old and adult rats indicated changes in the expression of both receptors during maturation. Immunohistochemistry of slices of the lumbar tract revealed that in an area of the ventral spinal cord that does not contain neuronal cell bodies, but mainly fibers and glial cells, both ER-alpha and ER-beta can be detected. Immunostaining is clearly nuclear, and, in the case of ER-alpha, both markedly positive and weakly labeled cells can be identified. ER-alpha is expressed during early development to progressively decline in the adult stage. In contrast, the ER-beta signal is low and peaks at postnatal day 25, whereas it is almost undetectable at other ages. Colocalization studies revealed that, at postnatal day 25, ER-alpha and ER-beta are expressed in astrocytes (identified by the specific marker glial fibrillar acidic protein) and oligodendrocytes (labeled by antimyelin 2',3'-cyclic nucleotide 3'-phosphodiesterase). The present results confirm the expression of ER-alpha and ER-beta in glial cells in vivo and suggest that, also in the spinal cord, glial cells may contribute to the effects of estrogen during development. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12806179     DOI: 10.1159/000070899

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  16 in total

1.  Studies on expression of FSH and its anti-apoptotic effects on ischemia injury in rat spinal cord.

Authors:  Chenyu Chu; Bainan Xu; Weiquan Huang
Journal:  J Mol Histol       Date:  2010-06-05       Impact factor: 2.611

2.  The cancer drug tamoxifen: a potential therapeutic treatment for spinal cord injury.

Authors:  Jutatip Guptarak; John E Wiktorowicz; Rovshan G Sadygov; Dragoslava Zivadinovic; Adriana A Paulucci-Holthauzen; Leoncio Vergara; Olivera Nesic
Journal:  J Neurotrauma       Date:  2013-12-11       Impact factor: 5.269

3.  Spinal cord injury causes a wide-spread, persistent loss of Kir4.1 and glutamate transporter 1: benefit of 17 beta-oestradiol treatment.

Authors:  Michelle L Olsen; Susan C Campbell; Michael B McFerrin; Candace L Floyd; Harald Sontheimer
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

4.  Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis.

Authors:  Allan J MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Laurie B Morales; Elizabeth Umeda; Benoit Boulat; Russell E Jacobs; Arthur W Toga; Rhonda R Voskuhl
Journal:  J Neurosci Res       Date:  2012-03-13       Impact factor: 4.164

5.  Neuroprotective effects of estradiol on motoneurons in a model of rat spinal cord embryonic explants.

Authors:  Andrea Cardona-Rossinyol; Margalida Mir; Víctor Caraballo-Miralles; Jerònia Lladó; Gabriel Olmos
Journal:  Cell Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.046

Review 6.  Estrogen receptor beta in the brain: from form to function.

Authors:  Michael J Weiser; Chad D Foradori; Robert J Handa
Journal:  Brain Res Rev       Date:  2007-06-26

Review 7.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

Review 8.  Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis.

Authors:  Robert J Handa; Michael J Weiser
Journal:  Front Neuroendocrinol       Date:  2013-11-16       Impact factor: 8.606

9.  Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice.

Authors:  Magdalena Polanczyk; Srikanth Yellayi; Alex Zamora; Sandhya Subramanian; Micah Tovey; Arthur A Vandenbark; Halina Offner; James F Zachary; Parley D Fillmore; Elizabeth P Blankenhorn; Jan-Ake Gustafsson; Cory Teuscher
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

10.  Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment.

Authors:  Seema Tiwari-Woodruff; Laurie Beth J Morales; Ruri Lee; Rhonda R Voskuhl
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.